Compounded Ophthalmic Medications
Atropine+.
Simplified Prescribing.
OSRX Atropine+ combines low-dose atropine with a lubricant and 50% less BAK preservative — compounded in our FDA-registered 503B outsourcing facility and available for shipment directly to your practice or your patient’s home.
- Three concentrations: 0.01%, 0.025%, and 0.05%
- 50% less BAK preservative
- Dedicated account representative for your practice
- Affordable, consistent supply you can rely on
Let’s Connect
Leave your details and an OSRX representative will reach out to you — no commitment, no pressure.
"*" indicates required fields
AS SEEN IN:
10,000+
Providers Nationwide
In Stock
Ready to Ship Today
1 Business Day
Prescriber Setup
Dedicated Rep
For Your Practice
WHY PRACTICES CHOOSE OSRX
Everything your practice needs
Quality Compounded Medications
Made to precise specifications with consistent, reliable quality your patients and practice can count on.
Affordable Pricing
Competitive pricing structures that improve affordability for your patients without sacrificing quality.
Simple Dosing Regimens
Formulations designed for patient compliance — easier routines mean better outcomes.
Direct-to-Patient Delivery
Ship bulk to your facility or directly to your patients' homes. We handle the logistics so you don't have to.
Dedicated Account Rep
You'll have a real person in your corner — someone who knows your practice and can answer questions fast.
Reliable Supply & Shipping
Consistent stock levels and fast fulfillment — so you can prescribe with confidence, not uncertainty.
Simplify Atropine+ Prescribing for Your Practice
It takes 60 seconds to get started. No account creation, no commitment.
Professional Disclosure:
*OSRX compounded post-op medications carry serious risks, including elevation of intraocular pressure, conjunctivitis, and decreased visual acuity. View potential adverse events and contraindications at: https://osrxpharmaceuticals.com/osrx-api-aecontraindication. For professional use only. OSRX specializes in customizing compounded medications to meet unique patient needs. Compounded drugs are not FDA-approved, which means they have not undergone FDA premarket review for safety, effectiveness, and quality